UCB以6000万美元预付款与Antengene达成T细胞衔接器合作协议。
UCB boards T cell engager train in $60M upfront deal with Antengene
生物技术与制药领域的最新动态
UCB boards T cell engager train in $60M upfront deal with Antengene
SLC4A1 mutations that cause distal renal tubular acidosis alter cytoplasmic pH and cellular autophagy
Pierre Fabre seeks to revive US approval chances for spurned cell therapy
Intracellular expression of a fluorogenic DNA aptamer using retron Eco2
Why it’s critical to close open steps in cell therapy manufacturing
Citrate clearance is a major function of aconitase 2 in the canonical TCA cycle
Pyruvate is a natural suppressor of interferon signaling by inducing STAT1 protein pyruvylation
High-resolution in situ structures of hantavirus glycoprotein tetramers
As CAR-T cell therapy gains ground on solid tumors, regulatory red tape hinders progress
Genetic network shaping Kenyon cell identity and function in Drosophila mushroom bodies
Single-cell ultra-high-throughput multiplexed chromatin accessibility and gene expression sequencing (SUM-seq) - Nature
Organism-wide cellular dynamics and epigenomic remodeling in mammalian aging | Science
A cellular basis for the mammalian nocturnal-diurnal switch | Science
Reconstitution of sex determination and the testicular niche using mouse pluripotent stem cells | Science
A Live-Cell NanoBRET Assay Shines Light on Toxic RNA–Protein Interactions in Myotonic Dystrophy
Whole-organ and whole-body 3D atlases enable cellome-wide profiling
Nuclear speckles enable processing of RNA from GC-rich isochores
Large-scale proteomics across neurological disorders uncovers biomarker panel and targets in multiple sclerosis
The MicrobeAtlas database: Global trends and insights into Earth’s microbial ecosystems
Vitamin B2 and B3 nutrigenomics reveals a therapy for NAXD disease